Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Laminaria japonica and Cistanche tubulosa extracts combined may effectively promote hair growth.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Two mouse mutations cause similar hair loss despite different skin changes.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

Wigs greatly improve life quality for hair loss patients.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Permanent hair dye may cause total hair loss.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The document says that there are treatments for hair and nail diseases.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.